Concepedia

Author

Jean Brooks

GlaxoSmithKline (United Kingdom)

Also Known As

Abbey Elie, Brooks, Jean, Brooks, Jean M., Donohue, James, J Brooks, Jean Brooks, Jean M Brooks, Ziyah Mehta

39

Publications

1.9K

Citations

13

H-Index

11

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)Research Triangle Park FoundationGlaxoSmithKline (United States)University of North Carolina at Chapel HillGlaxoSmithKline (Netherlands)
JB

About

Jean Brooks is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, pulmonary disease, and pulmonary medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

185

2

Pulmonary Disease

5

5

185

3

Pulmonary Medicine

4

4

175

4

Pharmacology

3

3

105

5

Asthma

1

1

53

Jean Brooks

×

14

Publications

1.8K

Citations

13

H-Index

YearCitations

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

David A. Lipson, Frank Barnhart, Noushin Brealey,

New England Journal of Medicine

2018

1.2K

Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD

Dave Singh, Jean Brooks, Gerry Hagan,

Thorax

2008

177

Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study

James F. Donohue, Dennis E. Niewoehner, Jean Brooks,

Respiratory Research

2014

92

A randomized, double-blind dose-ranging study of the novel LAMA GSK573719 in patients with COPD

James F. Donohue, Antonio Anzueto, Jean Brooks,

Respiratory Medicine

2012

65

Efficacy and Safety of Umeclidinium Added to Fluticasone Propionate/Salmeterol in Patients with COPD: Results of Two Randomized, Double-Blind Studies

Thomas M. Siler, Edward Kerwin, Karen Singletary,

COPD Journal of Chronic Obstructive Pulmonary Disease

2015

64

Bronchodilation of umeclidinium, a new long-acting muscarinic antagonist, in COPD patients

Marc Decramer, François Maltais, Gregory Feldman,

Respiratory Physiology & Neurobiology

2012

53

28-Day safety and tolerability of umeclidinium in combination with vilanterol in COPD: A randomized placebo-controlled trial

Gregory Feldman, R. Walker, Jean Brooks,

Pulmonary Pharmacology & Therapeutics

2012

42

Dose response of umeclidinium administered once or twice daily in patients with COPD: a randomised cross-over study

Alison Church, Misba Beerahee, Jean Brooks,

BMC Pulmonary Medicine

2014

29

Shortness of Breath with Daily Activities questionnaire: validation and responder thresholds in patients with chronic obstructive pulmonary disease

Michael L. Watkins, Teresa K. Wilcox, Maggie Tabberer,

BMJ Open

2013

25

Item selection, reliability and validity of the Shortness of Breath with Daily Activities (SOBDA) questionnaire: a new outcome measure for evaluating dyspnea in chronic obstructive pulmonary disease

Teresa K. Wilcox, Wen‐Hung Chen, Kellee Howard,

Health and Quality of Life Outcomes

2013

16

Page 1